MARCH7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.329600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.596000E-02
Normal-vs-Stage2
2.733600E-01
Normal-vs-Stage3
5.921900E-02
Normal-vs-Stage4
7.715800E-01
Stage1-vs-Stage2
6.027200E-01
Stage1-vs-Stage3
2.393200E-01
Stage1-vs-Stage4
2.852200E-01
Stage2-vs-Stage3
1.934200E-01
Stage2-vs-Stage4
4.402200E-01
Stage3-vs-Stage4
1.644970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.132000E-01
Normal-vs-AfricanAmerican
2.959800E-01
Normal-vs-Asian
5.373400E-01
Caucasian-vs-AfricanAmerican
7.905600E-01
Caucasian-vs-Asian
5.265200E-01
AfricanAmerican-vs-Asian
8.783000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.726230E-01
Normal-vs-Female
3.227000E-01
Male-vs-Female
6.153400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.284400E-01
Normal-vs-Age(41-60Yrs)
4.599000E-01
Normal-vs-Age(61-80Yrs)
1.957610E-01
Normal-vs-Age(81-100Yrs)
2.182300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.988800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.341200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.882000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.332100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.060390E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.313400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.205700E-02
Normal-vs-Daily Drinker
5.202100E-02
Normal-vs-Weekly Drinker
7.246200E-01
Normal-vs-Occasional Drinker
6.265400E-01
Normal-vs-Social Drinker
2.028200E-01
Non Drinker-vs-Daily Drinker
6.650000E-01
Non Drinker-vs-Weekly Drinker
3.553800E-01
Non Drinker-vs-Occasional Drinker
2.878100E-02
Non Drinker-vs-Social Drinker
5.142800E-01
Daily Drinker-vs-Weekly Drinker
2.731200E-01
Daily Drinker-vs-Occasional Drinker
1.667500E-02
Daily Drinker-vs-Social Drinker
3.240600E-01
Weekly Drinker-vs-Occasional Drinker
8.513400E-01
Weekly Drinker-vs-Social Drinker
5.636800E-01
Occasional Drinker-vs-Social Drinker
2.009600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.147600E-02
Normal-vs-Grade 2
3.182000E-02
Normal-vs-Grade 3
1.105910E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.356600E-03
Grade 1-vs-Grade 3
8.161600E-03
Grade 1-vs-Grade 4
9.147600E-02
Grade 2-vs-Grade 3
8.505400E-01
Grade 2-vs-Grade 4
3.182000E-02
Grade 3-vs-Grade 4
1.105910E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.992000E-02
Normal-vs-NonDiabetic
2.894000E-01
Diabetic-vs-NonDiabetic
8.805600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.961500E-02
Normal-vs-NoPancreatitis
2.587200E-01
Pancreatitis-vs-NoPancreatitis
2.729200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.389570E-01
Normal-vs-N1
2.770800E-01
N0-vs-N1
3.938200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.847200E-01
Normal-vs-TP53-NonMutant
1.127970E-01
TP53-Mutant-vs-TP53-NonMutant
1.441820E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
